Vedolizumab 300mg, 108 mg/0.68 mL Suppliers & Bulk Manufacturers
Available Forms: Injection / infusion
Available Strengths: 300mg, 108 mg/0.68 mL
Reference Brands: ENTYVIO (USA/EU)
Category: Gastrointestinal Drugs
Vedolizumab is a gut-selective monoclonal antibody that blocks the α4β7 integrin, preventing white blood cells from migrating into inflamed gastrointestinal tissue. It is used to treat adults with moderate to severe ulcerative colitis or Crohn’s disease who have not responded adequately to conventional therapies. Entyvio is administered either as an intravenous infusion (300 mg) or subcutaneous injection (108 mg). The drug is known for its targeted mechanism that reduces systemic immunosuppression compared to other biologics.
Vedolizumab — third party manufacturing & bulk supply
Vedolizumab 300mg, 108 mg/0.68 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Vedolizumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Vedolizumab →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Vedolizumab is used to treat moderate to severe ulcerative colitis and Crohn’s disease in adults. It helps reduce inflammation in the digestive tract and maintain remission by blocking the movement of inflammatory white blood cells (lymphocytes) into the gut, which are responsible for causing inflammation.
Vedolizumab is made from Vedolizumab, a humanized monoclonal antibody that targets the α4β7 integrin receptor on gut-specific lymphocytes, thereby preventing their migration to inflamed intestinal tissue.
The trade name of Vedolizumab is Entyvio.
Vedolizumab (En tyvio)is developed and manufactured by Takeda Pharmaceutical Company Limited, Japan, and marketed globally under regulatory approvals.
The generic name of Vedolizumab is Vedolizumab.
The brand name of Vedolizumab is Entyvio.
Vedolizumab is manufactured by Takeda Pharmaceutical Company in Japan and its production facilities in the United States and Europe under strict GMP guidelines.
Related Products
Bismuth Subsalicylate
Strength:
262 mg, 525 mg
Form: Oral suspension / Tablet
Reference Brands: Pepto-Bismol (USA/LATAM),
View Details
Quick Response Guaranteed | Verified Suppliers
